Free 30-min Web3 Consultation
Book Consultation
Smart Contract Security Audits
View Audit Services
Custom DeFi Protocol Development
Explore DeFi
Full-Stack Web3 dApp Development
View App Services
Free 30-min Web3 Consultation
Book Consultation
Smart Contract Security Audits
View Audit Services
Custom DeFi Protocol Development
Explore DeFi
Full-Stack Web3 dApp Development
View App Services
Free 30-min Web3 Consultation
Book Consultation
Smart Contract Security Audits
View Audit Services
Custom DeFi Protocol Development
Explore DeFi
Full-Stack Web3 dApp Development
View App Services
Free 30-min Web3 Consultation
Book Consultation
Smart Contract Security Audits
View Audit Services
Custom DeFi Protocol Development
Explore DeFi
Full-Stack Web3 dApp Development
View App Services
healthcare-and-privacy-on-blockchain
Blog

Why sMPC is the Unsung Hero of Collaborative Cancer Research

Hospitals and pharma giants sit on petabytes of untapped patient data, locked in silos by privacy laws. This analysis argues that Secure Multi-Party Computation (sMPC) is the foundational cryptographic primitive enabling a new paradigm: collaborative AI model training without data ever leaving its source, finally making privacy-preserving, large-scale medical research viable.

introduction
THE SILOED DATA PROBLEM

The Multi-Billion Dollar Data Prison

Medical research is crippled by data silos, where patient privacy laws create a $200B annual inefficiency by preventing collaborative analysis.

Patient data is a trapped asset. HIPAA and GDPR create legal moats around clinical datasets, making cross-institutional research a logistical and legal nightmare. This fragmentation forces each research group to operate with statistically insignificant sample sizes.

Federated learning is insufficient. Models like Google's TensorFlow Federated only share gradients, not the raw data. This fails for novel biomarker discovery, which requires analyzing the underlying genomic sequences and patient histories that gradients obscure.

Secure Multi-Party Computation (sMPC) breaks the prison. Protocols like Inpher's Secret Computing or Partisia's MPC enable a global query across encrypted datasets. A researcher at Sloan Kettering can compute a correlation against encrypted data from the Mayo Clinic without either party seeing the other's raw data.

The economic incentive is clear. A 2023 JAMA study quantified the cost of non-interoperable health data at over $200 billion annually in the US alone. sMPC converts compliance cost centers into monetizable, privacy-preserving data assets.

thesis-statement
THE DATA

Thesis: sMPC is the Foundational Layer for Trustless Medical Collaboration

Secure Multi-Party Computation enables collaborative analysis of sensitive genomic data without exposing the raw information.

sMPC enables private computation. It allows hospitals like Mayo Clinic and research consortiums to run algorithms on combined datasets. The raw patient data never leaves its secure enclave, preserving privacy and regulatory compliance.

It replaces the data silo model. Traditional collaboration requires centralized data lakes, creating security and legal bottlenecks. sMPC protocols, similar to those used by NuCypher for secret management, compute across distributed nodes. This creates a virtual data pool without physical aggregation.

The cryptographic guarantee is non-negotiable. Unlike federated learning which shares model updates, sMPC provides information-theoretic security. The output is the only data revealed, a standard necessary for HIPAA and GDPR adherence in multi-institutional studies.

Evidence: The iDASH genomics privacy competition has featured sMPC solutions since 2016. Winning entries demonstrate feasibility, with one 2021 entry performing a genome-wide association study on 25,000 records across three institutions in under 15 hours.

DECENTRALIZED HEALTHCARE DATA

Privacy Tech Showdown: sMPC vs. The Alternatives

A first-principles comparison of cryptographic primitives for enabling collaborative analysis of sensitive genomic and patient data without centralizing trust.

Core Metric / CapabilitySecure Multi-Party Computation (sMPC)Fully Homomorphic Encryption (FHE)Zero-Knowledge Proofs (ZKPs)

Cryptographic Guarantee

Data never exists in complete form

Data is encrypted during computation

Proof of statement validity, not data itself

Computational Overhead

100-1000x plaintext (network-bound)

10,000-1,000,000x plaintext

~1000x for proof generation, ~1x for verification

Primary Use Case

Joint statistical analysis (e.g., GWAS)

Encrypted database queries

Proving compliance (e.g., patient consent)

Output Granularity

Aggregate results (mean, variance)

Encrypted query results

Boolean proof (true/false)

Trust Assumptions

Honest majority of computation nodes

Single key holder or TEE

Cryptographic soundness only

Real-World Adoption (Biotech)

Trials by Pfizer, Roche (via Partisia, Inpher)

Early R&D (IBM, Microsoft)

zkKYC for trial enrollment (Sismo, Polygon ID)

Data Utility Post-Processing

Full statistical power preserved

Limited by encrypted operation set

No raw data output, only proof

Key Management Burden

Distributed key shares (no single point of failure)

Centralized secret key (major risk vector)

Prover/Verifier keys, no data keys

deep-dive
THE PRIVACY ENGINE

Under the Hood: How sMPC Unlocks the Research Consortium

Secure Multi-Party Computation (sMPC) enables collaborative analysis of sensitive genomic data without exposing the raw information, solving the fundamental trust barrier in medical research.

sMPC is a cryptographic primitive that allows multiple parties to jointly compute a function over their private inputs. In a research consortium, each hospital's patient data remains encrypted and locally stored, while the collective computation yields a global result, like a statistical correlation between a genetic marker and drug efficacy.

This replaces centralized data lakes. Traditional models like the NIH's dbGaP require data submission to a central authority, creating a single point of failure for security and control. sMPC architectures, similar to privacy-preserving networks like Oasis Network or Enigma, keep data sovereign and in-situ.

The protocol enforces privacy by design. Unlike federated learning which shares model updates, sMPC's cryptographic guarantees ensure no party learns anything beyond the final aggregated output. This meets stringent regulations like HIPAA and GDPR by construction, not by policy.

Evidence: The iDASH genome privacy competition has benchmarked sMPC frameworks for years, with winning solutions from teams using libraries like MP-SPDZ achieving secure genome-wide association studies on cohorts from 10+ institutions without data leakage.

case-study
PRIVACY-PRESERVING ONCOLOGY

sMPC in the Wild: From Theory to Tumor Analysis

Secure Multi-Party Computation (sMPC) enables global cancer research without exposing sensitive patient data, breaking down the silos that cripple medical progress.

01

The Problem: Data Silos Kill Collaboration

Patient genomic and treatment data is locked in institutional vaults due to HIPAA, GDPR, and proprietary concerns. This creates fatal inefficiencies:\n- ~80% of clinical data is unstructured and unusable for cross-institution analysis\n- Drug discovery cycles are slowed by months or years of legal negotiation\n- Rare cancer research is geographically bottlenecked

80%
Data Unusable
18-24mo
Delay Added
02

The sMPC Solution: Federated Learning on Encrypted Data

sMPC protocols allow algorithms to train on distributed datasets without raw data ever leaving its source. This enables:\n- Global model training across hospitals in the US, EU, and Asia simultaneously\n- Cryptographic guarantees that patient PII and genomic data remain encrypted\n- Real-time collaboration at the speed of computation, not legal review

0-Exposure
Raw Data
Global
Model Scale
03

Entity in Action: Owkin's FL for Drug Discovery

Owkin uses sMPC-powered federated learning to connect top-tier cancer centers like MIT and Gustave Roussy. Their platform demonstrates:\n- >50% improvement in predicting patient response to immunotherapy\n- Secure analysis of multimodal data (histology slides, genomics, clinical records)\n- A viable business model where data providers are compensated for insights, not data

>50%
Prediction Gain
Multi-Modal
Data Types
04

The New Battleground: Compute vs. Compliance Cost

sMPC shifts the primary cost from legal/compliance overhead to pure computation. The trade-off is clear:\n- ~30-50% higher compute cost vs. centralized analysis\n- ~90% lower legal/contracting cost and timeline\n- Net positive ROI for large-scale, sensitive research where centralization is impossible

+40%
Compute Cost
-90%
Legal Cost
05

Beyond Academia: Pharma's $10B+ Efficiency Play

Major pharmaceutical companies are deploying sMPC to streamline clinical trials and biomarker discovery. The impact:\n- Faster patient cohort identification across disparate hospital networks\n- Reduced trial failure rates via better predictive models on real-world data\n- Direct integration with CROs (Contract Research Organizations) like IQVIA

$10B+
Market Efficiency
30% Faster
Cohort ID
06

The Next Frontier: sMPC Meets On-Chain Incentives

Blockchain and sMPC convergence creates auditable, incentive-aligned research networks. This mirrors DeFi primitives:\n- Tokenized data access where hospitals earn rewards for contribution (cf. Ocean Protocol)\n- Verifiable computation proofs ensuring model integrity (cf. zk-proofs)\n- Automated, compliant royalty streams for data providers upon drug commercialization

Auditable
Contributions
Auto-Royalties
Incentive Model
risk-analysis
WHY IT'S THE UNSUNG HERO

The Bear Case: sMPC's Real-World Friction

Secure Multi-Party Computation (sMPC) is the cryptographic backbone enabling competing institutions to analyze sensitive patient data without ever exposing it.

01

The Data Silos Problem

Cancer research is paralyzed by proprietary patient data locked in hospital silos. Traditional data-sharing agreements take 6-18 months to negotiate and carry massive liability.

  • Enables cross-institutional training of AI models on 10-100x larger datasets.
  • Eliminates legal and compliance bottlenecks for collaborative studies.
6-18mo
Time Saved
10-100x
Data Scale
02

Privacy-Preserving Federated Learning

sMPC protocols like those from OpenMined or Inpher allow model training on encrypted data. Each hospital's server computes on local data, and only encrypted model updates are shared.

  • Zero raw data ever leaves the source institution, satisfying HIPAA/GDPR.
  • Aggregated insights reveal patterns invisible to any single research center.
0%
Data Exposure
HIPAA
Compliant
03

The Cost of Centralized Trust

Centralizing sensitive genomic data in a single repository creates a high-value attack target and requires massive infrastructure. sMPC distributes both the data and the risk.

  • Avoids building a $100M+ centralized data fortress vulnerable to breaches.
  • Shifts security model from perimeter defense to cryptographic guarantees.
$100M+
Cost Avoided
Attack Surface
Reduced
04

Real-World Throughput Friction

sMPC's cryptographic overhead introduces latency, making real-time analysis of large genomic datasets (e.g., 1000+ whole genomes) a challenge. This is the core engineering bear case.

  • Requires specialized hardware (SGX, TEEs) or optimized protocols (SPDZ, ABY) for performance.
  • Trade-off is absolute privacy for ~10-100x slower computation vs. plaintext.
10-100x
Slower Compute
SGX/TEE
Requirement
future-outlook
THE INFRASTRUCTURE

The 5-Year Horizon: From Niche to Network

Secure Multi-Party Computation (sMPC) will become the foundational privacy layer enabling global, trust-minimized collaboration on sensitive genomic data.

sMPC enables federated analysis without data centralization. Researchers query a global dataset where raw genomic sequences never leave local custody, solving the privacy-compliance deadlock that stalls multi-institutional studies.

The network effect is non-linear. Each new hospital or biobank joining an sMPC network like Federated Learning or Oasis Labs' privacy framework increases the combinatorial value of analysis exponentially, not linearly.

It outcompetes pure homomorphic encryption. While Fully Homomorphic Encryption (FHE) is computationally intensive for large datasets, sMPC protocols achieve practical performance for complex queries, making them the operational choice for real-world research.

Evidence: The NIH's All of Us research program aims to sequence 1 million genomes; sMPC networks provide the only scalable model for permitting external researchers to analyze this data without creating a monolithic, high-risk target.

takeaways
CRYPTO'S REAL-WORLD IMPACT

TL;DR for the Busy CTO

sMPC is not just for DeFi keys; it's the critical infrastructure enabling secure, multi-party computation on sensitive data without centralized trust.

01

The Problem: Data Silos Kill Research

Hospitals and pharma giants hoard patient data due to HIPAA/GDPR liability and competitive fears. This creates isolated data lakes, crippling the statistical power needed for breakthroughs.\n- Months of legal negotiation per collaboration\n- Impossible to audit data usage without exposing it

80%
Data Unused
6-12mo
Delay
02

The Solution: Compute on Encrypted Data

sMPC protocols (like those from Partisia, Inpher) allow algorithms to run on data split between multiple parties. No single entity ever sees the raw input.\n- Privacy-Preserving Analytics: Train ML models on combined datasets\n- Provenance & Audit Trail: Every computation is cryptographically verifiable

Zero-Trust
Model
100%
Data Obfuscated
03

The Bridge: On-Chain Coordination & Incentives

Blockchains like Ethereum or Solana orchestrate the sMPC network and create economic models for data contributors. This turns compliance into a programmable layer.\n- Tokenized Data Rights: Patients/Institutions monetize access\n- Automated Compliance: Smart contracts enforce usage terms and distribute rewards

~60s
Settlement
Auditable
By Design
04

The Outcome: Federated Learning at Scale

This stack enables a global, privacy-first research network. Imagine a model trained on 10M oncology records without any patient data leaving its source hospital.\n- Faster Drug Discovery: Identify biomarkers from broader, real-world data\n- Reduced Trial Costs: Pre-screen candidates with higher precision

10x
Cohort Size
-70%
Recruitment Cost
ENQUIRY

Get In Touch
today.

Our experts will offer a free quote and a 30min call to discuss your project.

NDA Protected
24h Response
Directly to Engineering Team
10+
Protocols Shipped
$20M+
TVL Overall
NDA Protected Directly to Engineering Team